(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide

C126H189F3N24O12 — CID 158582425

IUPAC(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide
SMILESCC(C)Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCNC(C)C.CC(C)N(CCn1c(CCC(F)(F)F)nc2cc(/C=C/C(=O)NO)ccc21)C(C)C.CC(C)NCCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21.CC(Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCCNC(C)C)CC(C)(C)C.CCCCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC.CCNCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21
InChIInChI=1S/C24H38N4O2.C22H34N4O2.C21H29F3N4O2.C21H32N4O2.2C19H28N4O2/c1-17(2)25-12-7-13-28-21-10-8-19(9-11-23(29)27-30)15-20(21)26-22(28)14-18(3)16-24(4,5)6;1-4-7-8-9-10-21-23-19-17-18(12-14-22(27)24-28)11-13-20(19)26(21)16-15-25(5-2)6-3;1-14(2)27(15(3)4)11-12-28-18-7-5-16(6-8-20(29)26-30)13-17(18)25-19(28)9-10-21(22,23)24;1-15(2)22-11-6-12-25-18-9-7-16(8-10-20(26)24-27)13-17(18)23-19(25)14-21(3,4)5;1-13(2)11-18-21-16-12-15(6-8-19(24)22-25)5-7-17(16)23(18)10-9-20-14(3)4;1-5-20-10-11-23-16-8-6-14(7-9-18(24)22-25)12-15(16)21-17(23)13-19(2,3)4/h8-11,15,17-18,25,30H,7,12-14,16H2,1-6H3,(H,27,29);11-14,17,28H,4-10,15-16H2,1-3H3,(H,24,27);5-8,13-15,30H,9-12H2,1-4H3,(H,26,29);7-10,13,15,22,27H,6,11-12,14H2,1-5H3,(H,24,26);5-8,12-14,20,25H,9-11H2,1-4H3,(H,22,24);6-9,12,20,25H,5,10-11,13H2,1-4H3,(H,22,24)/b11-9+;14-12+;8-6+;10-8+;8-6+;9-7+
InChIKeyHTKLYLGTASNMSD-XWAHWJEESA-N
MW2289.05 g/mol
LogP21.78
Rot. Bonds54

About (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide

(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide (PubChem CID 158582425) has the molecular formula C126H189F3N24O12 and a molecular weight of 2289.05 g/mol. Its IUPAC name is (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide.

Molecular Properties

Compound Name(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide
PubChem CID158582425
Molecular FormulaC126H189F3N24O12
Molecular Weight2289.05 g/mol
Exact Mass2287.49
IUPAC Name(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide
SMILESCC(C)Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCNC(C)C.CC(C)N(CCn1c(CCC(F)(F)F)nc2cc(/C=C/C(=O)NO)ccc21)C(C)C.CC(C)NCCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21.CC(Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCCNC(C)C)CC(C)(C)C.CCCCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC.CCNCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21
InChIInChI=1S/C24H38N4O2.C22H34N4O2.C21H29F3N4O2.C21H32N4O2.2C19H28N4O2/c1-17(2)25-12-7-13-28-21-10-8-19(9-11-23(29)27-30)15-20(21)26-22(28)14-18(3)16-24(4,5)6;1-4-7-8-9-10-21-23-19-17-18(12-14-22(27)24-28)11-13-20(19)26(21)16-15-25(5-2)6-3;1-14(2)27(15(3)4)11-12-28-18-7-5-16(6-8-20(29)26-30)13-17(18)25-19(28)9-10-21(22,23)24;1-15(2)22-11-6-12-25-18-9-7-16(8-10-20(26)24-27)13-17(18)23-19(25)14-21(3,4)5;1-13(2)11-18-21-16-12-15(6-8-19(24)22-25)5-7-17(16)23(18)10-9-20-14(3)4;1-5-20-10-11-23-16-8-6-14(7-9-18(24)22-25)12-15(16)21-17(23)13-19(2,3)4/h8-11,15,17-18,25,30H,7,12-14,16H2,1-6H3,(H,27,29);11-14,17,28H,4-10,15-16H2,1-3H3,(H,24,27);5-8,13-15,30H,9-12H2,1-4H3,(H,26,29);7-10,13,15,22,27H,6,11-12,14H2,1-5H3,(H,24,26);5-8,12-14,20,25H,9-11H2,1-4H3,(H,22,24);6-9,12,20,25H,5,10-11,13H2,1-4H3,(H,22,24)/b11-9+;14-12+;8-6+;10-8+;8-6+;9-7+
InChIKeyHTKLYLGTASNMSD-XWAHWJEESA-N
XLogP21.78
TPSA457.50 Ų
H-Bond Donors16
H-Bond Acceptors30
Rotatable Bonds54
Heavy Atoms165
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002289.05
LogP ≤ 521.78
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide?
The IUPAC name of (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide (CID 158582425) is (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide.
What is the SMILES notation for (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide?
The canonical SMILES for (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide is CC(C)Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCNC(C)C.CC(C)N(CCn1c(CCC(F)(F)F)nc2cc(/C=C/C(=O)NO)ccc21)C(C)C.CC(C)NCCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21.CC(Cc1nc2cc(/C=C/C(=O)NO)ccc2n1CCCNC(C)C)CC(C)(C)C.CCCCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC.CCNCCn1c(CC(C)(C)C)nc2cc(/C=C/C(=O)NO)ccc21.
What is the InChIKey of (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide?
The InChIKey is HTKLYLGTASNMSD-XWAHWJEESA-N. The full InChI is InChI=1S/C24H38N4O2.C22H34N4O2.C21H29F3N4O2.C21H32N4O2.2C19H28N4O2/c1-17(2)25-12-7-13-28-21-10-8-19(9-11-23(29)27-30)15-20(21)26-22(28)14-18(3)16-24(4,5)6;1-4-7-8-9-10-21-23-19-17-18(12-14-22(27)24-28)11-13-20(19)26(21)16-15-25(5-2)6-3;1-14(2)27(15(3)4)11-12-28-18-7-5-16(6-8-20(29)26-30)13-17(18)25-19(28)9-10-21(22,23)24;1-15(2)22-11-6-12-25-18-9-7-16(8-10-20(26)24-27)13-17(18)23-19(25)14-21(3,4)5;1-13(2)11-18-21-16-12-15(6-8-19(24)22-25)5-7-17(16)23(18)10-9-20-14(3)4;1-5-20-10-11-23-16-8-6-14(7-9-18(24)22-25)12-15(16)21-17(23)13-19(2,3)4/h8-11,15,17-18,25,30H,7,12-14,16H2,1-6H3,(H,27,29);11-14,17,28H,4-10,15-16H2,1-3H3,(H,24,27);5-8,13-15,30H,9-12H2,1-4H3,(H,26,29);7-10,13,15,22,27H,6,11-12,14H2,1-5H3,(H,24,26);5-8,12-14,20,25H,9-11H2,1-4H3,(H,22,24);6-9,12,20,25H,5,10-11,13H2,1-4H3,(H,22,24)/b11-9+;14-12+;8-6+;10-8+;8-6+;9-7+.
What are the key properties of (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide?
(E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide has a molecular weight of 2289.05 g/mol, XLogP of 21.78, 54 rotatable bonds, 16 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[1-[2-(diethylamino)ethyl]-2-hexylbenzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[2-(ethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[2-(2,2-dimethylpropyl)-1-[3-(propan-2-ylamino)propyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-3-[1-[2-[di(propan-2-yl)amino]ethyl]-2-(3,3,3-trifluoropropyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide;(E)-N-hydroxy-3-[2-(2-methylpropyl)-1-[2-(propan-2-ylamino)ethyl]benzimidazol-5-yl]prop-2-enamide;(E)-N-hydroxy-3-[1-[3-(propan-2-ylamino)propyl]-2-(2,4,4-trimethylpentyl)benzimidazol-5-yl]prop-2-enamide is sourced from PubChem (CID 158582425), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).